Price Alert

Collegium Pharmaceutical ... (COLL)

NASDAQ: COLL · Real-Time Price · USD

37.71

0.55 (1.48%)

At close: Aug 15, 2025, 3:59 PM

37.74

0.08%

After-hours: Aug 15, 2025, 04:34 PM EDT

Collegium Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	664.28M	631.45M	599.25M	576.65M	566.92M	566.77M	546.64M	536.95M	524.95M	463.93M	361.68M	313.5M	272.9M	276.87M	325.78M	326.11M	321.23M
Cost of Revenue	281.07M	254.1M	225.56M	219.45M	226.7M	240.6M	265.31M	277.09M	286.56M	254.44M	203.31M	167.87M	129.38M	126.25M	129.53M	127.79M	124.78M
Gross Profit	383.21M	377.34M	373.69M	357.2M	340.22M	326.17M	281.33M	259.86M	238.39M	209.49M	158.37M	145.64M	143.51M	150.62M	196.24M	198.32M	196.45M
Operating Income	142.11M	169.9M	193.47M	203.65M	191.81M	166.96M	74.95M	50.41M	25.88M	-8.75M	-12.56M	-18.87M	-13.57M	17.63M	66.75M	72.22M	72.36M
Interest Income	11.71M	13.98M	16.47M	17.73M	17.36M	15.62M	12.34M	7.81M	3.79M	1.05M	23K	15K	13K	12K	12K	12K	23K
Pretax Income	65.07M	98.57M	128.01M	141.21M	129.91M	75.73M	21.23M	-6.12M	-30.56M	-28.85M	-59.93M	-52.33M	-34.69M	-3.37M	42.76M	45.29M	42.61M
Net Income	43.89M	69.19M	88.59M	99.89M	93.29M	48.16M	9.02M	-11.16M	-29.36M	-25M	-42.84M	-35.25M	42.79M	71.52M	103.51M	106.75M	41.96M
Selling & General & Admin	244.8M	210.36M	180.21M	153.56M	148.41M	159.21M	164.3M	167.37M	170.43M	172.19M	160.76M	152.9M	142.01M	118.96M	119.18M	115.09M	114.05M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	-3.98M	-3.98M	-3.98M	n/a	5.59M	7.04M	10.5M	9.45M	10.31M	11.01M	10.04M
Other Expenses	-3.7M	-2.91M	n/a	n/a	n/a	n/a	3.98M	3.98M	3.98M	3.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	241.1M	207.45M	180.21M	153.56M	148.41M	159.21M	164.3M	167.37M	170.43M	176.17M	166.35M	159.94M	152.52M	128.41M	129.5M	126.1M	124.08M
Interest Expense	77.42M	73.97M	70.6M	72.97M	79.25M	83.34M	84.63M	82.91M	78.81M	63.21M	47.4M	33.46M	21.12M	21.01M	23.99M	26.94M	29.78M
Selling & Marketing Expenses	n/a	n/a	7.41M	7.41M	7.41M	7.41M	11.74M	11.74M	11.74M	11.74M	4.19M	4.19M	4.19M	4.19M	-87.01M	-60.58M	-31.26M
Cost & Expenses	525.09M	464.47M	405.77M	373.01M	375.12M	399.81M	429.61M	444.46M	456.99M	430.61M	369.66M	327.81M	281.9M	254.66M	259.03M	253.89M	248.86M
Income Tax Expense	21.17M	29.38M	39.41M	41.32M	36.62M	27.58M	12.22M	5.04M	-1.2M	-3.85M	-17.09M	-17.08M	-77.48M	-74.89M	-60.74M	-61.46M	642K
Shares Outstanding (Basic)	31.79M	32.08M	32.26M	32.43M	32.33M	32.3M	33.74M	34.62M	34.32M	33.58M	34.06M	34M	33.51M	34.11M	35.37M	35.3M	34.95M
Shares Outstanding (Diluted)	32.84M	40.11M	40.16M	40.38M	41.44M	41.28M	42.06M	42.85M	34.32M	33.58M	34.57M	34M	33.67M	34.12M	36.26M	41.29M	41.16M
EPS (Basic)	1.40	2.18	2.78	3.06	2.84	1.47	0.27	-0.33	-0.86	-0.74	-1.26	-1.04	1.17	2.01	2.94	3.04	1.21
EPS (Diluted)	1.22	1.86	2.32	2.58	2.40	1.18	0.15	-0.37	-0.86	-0.74	-1.26	-1.05	0.89	1.69	2.62	2.72	1.16
EBITDA	332.78M	341.7M	346.72M	357.66M	355.42M	308.07M	257.62M	229.39M	201.02M	168.76M	100.86M	73.83M	57.92M	86.58M	135.55M	140.77M	140.68M
EBIT	142.49M	172.54M	198.61M	214.19M	209.16M	159.07M	105.86M	76.79M	48.25M	34.37M	-12.54M	-18.86M	-13.57M	17.64M	66.76M	72.23M	72.39M
Depreciation & Amortization	190.29M	169.16M	148.11M	143.47M	146.25M	149M	151.75M	152.59M	152.77M	134.39M	113.39M	92.69M	71.49M	68.94M	68.79M	68.53M	68.3M